Anthony DiGiandomenico

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

• Identityunclaimed
  Published
• Evidencecorroborated
  Published
• Evaluationnot_evaluated
  Published
• MonitoringNot yet published for this record.
  Not published
• AuthorityNot yet published for this record.
  Not published
• Freshnesscurrent
  Published

Seats held as a director, as published in the cited sources.

1. 2026 to end not published
   Executive title: Head of New Venture Discovery, and DirectorOrganization not published
   E3
2. 2026 to end not published
   Executive title: DirectorOrganization not published
   E1E2E4
3. Dates not published
   Executive title: Head of New Venture DiscoveryOrganization not published
   E7

No education, credentials, or certifications are published in this record.

Who may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

• Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
• Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
• Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
• Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.

Each relationship is one Claim rendered on every record it connects.

• MC
  MDB Capital Holdings, LLCDirector, 2021 to present
  person:anthony-digiandomenico:role:1
• E
  EXOZYMES INC.Director, 2019 to present
  person:anthony-digiandomenico:role:2
• EL
  ENDRA Life Sciences Inc.Director, 2013 to present
  person:anthony-digiandomenico:role:3
• CT
  ClearSign Technologies CorpDirector, Current · dates not published
  person:anthony-digiandomenico:role:4
• ON
  Organization not publishedExecutive title: Head of New Venture Discovery, and Director, 2026 to end not published; Executive title: Director, 2026 to end not published; Executive title: Head of New Venture Discovery, Dates not published
  person:anthony-digiandomenico:executive_title:16, person:anthony-digiandomenico:executive_title:14 +1

This record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.

Basis

Public role at an organization in the published Registry

Sources

16 evidence records cited. 0 with redistribution rights.

Never published

Home address, family, personal contacts, health, and history unrelated to the public role

Profile claimed

No

Open disputes

0

Identity ownership

unclaimed

If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.

1. E1
   CLIR DEF 14A executive officers

   SEC EDGAR. sec filing. Published Apr 28, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
2. E2
   NDRA 10-K executive officers

   SEC EDGAR. sec filing. Published Mar 31, 2026. Retrieved May 16, 2026. Cited by 6 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
3. E3
   MDBH 10-K executive officers

   SEC EDGAR. sec filing. Published Mar 31, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
4. E4
   EXOZ 10-K executive officers

   SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
5. E5
   CLIR DEF 14A director slate

   SEC EDGAR. sec filing. Published Feb 2, 2026. Retrieved May 15, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
6. E6
   Source title not published

   sec proxy. Published Feb 2, 2026. Retrieved Apr 25, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
7. E7
   MDBH DEF 14A director slate

   SEC EDGAR. sec filing. Published Nov 14, 2025. Retrieved May 16, 2026. Cited by 4 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
8. E8
   Source title not published

   sec proxy. Published Nov 14, 2025. Retrieved Apr 25, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
9. E9
   NDRA DEF 14A director slate

   SEC EDGAR. sec filing. Published Oct 28, 2025. Retrieved May 16, 2026. Cited by 5 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
10. E10
    Source title not published

    sec proxy. Published Oct 28, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
11. E11
    EXOZ DEF 14A director slate

    SEC EDGAR. sec filing. Published Jun 20, 2025. Retrieved May 15, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
12. E12
    Source title not published

    sec proxy. Published Jun 20, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
13. E13
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
14. E14
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
15. E15
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
16. E16
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

• Anthony DiGiandomenico seat on MDB Capital Holdings, LLC, effective 2021-01-01.
• Anthony DiGiandomenico seat on EXOZYMES INC., effective 2019-01-01.
• Anthony DiGiandomenico seat on ENDRA Life Sciences Inc., effective 2013-01-01.